Dalman Adverse Reactions

Data from large clinical studies have been used to determine the incidence of adverse events, from very common to rare. Frequencies of other adverse events (<1/10,000) were determined from post-marketing data and are based on the reporting rate rather than an actual frequency.
The frequency classification is as follows: Very common ≥1/10; Common ≥1/100 and <1/10; Uncommon ≥1/1000 and <1/100; Rare ≥1/10,000 and <1/1000; Very rare <1/10,000; Unknown (it cannot be predicted on the basis of available data).
Immune system diseases: Very rare: Hypersensitivity reactions, anaphylaxis/anaphylactic reactions, bronchospasm, skin rash, edema of the face or tongue.
Nervous System Disorders: Common: Headache, bad taste in mouth, bad odour.
As with other nasal sprays, bad taste in the mouth, bad odor and headache have been reported.
Eye diseases: Very rare: Glaucoma, increased intraocular pressure, cataract.
Few spontaneous reports have been described following long-term therapy. However, clinical studies lasting up to one year have shown that intranasal fluticasone propionate is not associated with an increased incidence of eye events such as cataracts, increased intraocular pressure, or glaucoma.
Diseases of the respiratory system: Very common: Epistaxis.
Common: Nasal dryness, nasal irritation, dry throat, throat irritation.
As with other intranasal medications, dryness, irritation and epistaxis of the nose and throat have been reported.
Very rare: Nasal septal perforation.
Cases of nasal septal perforation have been reported following the use of intranasal corticosteroids.